NCI Council of Research Advocates Meets To Accelerate Immunotherapy Research

Wendy Selig, President & CEO, Melanoma Research Alliance and Max Wallace, CEO, ABC2  

On October 21st, the National Cancer Institute's Council of Research Advocates (NCRA) held their quarterly meeting.  The topic of discussion was cancer immunotherapy research. NCI Director Dr. Harold Varmus, cancer researchers and advocates discussed a wide-range of issues, including: therapeutic cancer vaccines, the role of adoptive T-cell therapy, regulatory advances in immunotherapy and ways advocates can advance cancer immunotherapy research. 

The NCRA, previously known as the Director’s Consumer Liaison Group (DCLG), is the only federal advisory committee comprised of advocate leaders at NCI. Max Wallace, CEO of Accelerate Brain Cancer Cure, is the chair of the group.  NCRA members are chosen for their expert knowledge of issues of importance to the cancer research community.

The NCRA focuses on matters that facilitate research and often identifies and responds to challenges facing the Institute at the request of NCI leadership. In addition, NCRA members bring their unique skills and perspectives by identifying new approaches, promoting innovation, recognizing unforeseen risks or barriers, and identifying unintended consequences that could result from NCI decisions. NCRA meetings are open to the public and focus on enhancing community input, optimizing community outreach, and promoting strong collaborations to improve research outcomes.

Information on past NCRA/DCLG meetings, including agendas and summaries, can be found through the NCI Division of Extramural Activities.

Share |
August 13, 2022 05:05 PM
Brain Tumor Imaging Protocol will reduce variability in magnetic resonance imaging and increase accuracy in determining progression and response of investigational therapies
July 15, 2022 03:44 PM
Progress continues on the ABC2-funded immunotherapy research by Catherine Flores and her team at UF.
July 14, 2022 03:47 PM
Guest blogger Shawn Peters shares why he's running the 2015 Marine Corps Marathon to support ABC2.

Join us in our fight for a cure!